Associated Papers
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants.
Lerche S et al.
Npj Parkinson's Disease, 2025
40324994 (PubMed )
Supplement: 41531_2025_978_MOESM1_ESM.pdf
A PheWAS approach to identify associations of GBA1 variants with comprehensive phenotypes beyond neurological diseases.
Yang J et al.
Npj Parkinson's Disease, 2025
40097465 (PubMed )
Supplement: 41531_2025_901_MOESM1_ESM.xlsx › Supplementary_Table_4
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.
Roeben B et al.
Npj Parkinson's Disease, 2024
GBA1 in Parkinson's disease: variant detection and pathogenicity scoring matters.
Gabbert C et al.
Bmc Genomics, 2023
37312046 (PubMed )
Supplement: 12864_2023_9417_MOESM1_ESM.pdf
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PDGBA.
Lerche S et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2021
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Alcalay RN et al.
Annals of Clinical and Translational Neurology, 2020
32888397 (PubMed )
Supplement: ACN3-7-1816-s001.docx
Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA et al.
Molecular Neurodegeneration, 2016
Select a paper to view details